Literature DB >> 33386772

Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital.

Sören Krüger1, Miriam Leskien2, Patricia Schuller2, Christiane Prifert3, Benedikt Weißbrich3, Ulrich Vogel1,2, Manuel Krone1.   

Abstract

Anamnestic screening of symptoms and contact history is applied to identify coronavirus disease 2019 (COVID-19) patients on admission. However, asymptomatic and presymptomatic patients remain undetected although the viral load may be high. In this retrospective cohort study, all hospitalized patients who received polymerase chain reaction (PCR) admission testing from March 26th until May 24th, 2020 were included. Data on COVID-19-specific symptoms and contact history to COVID-19 cases were retrospectively extracted from patient files and from contact tracing notes. The compliance to the universal testing protocol was high with 90%. Out of 6940 tested patients, 27 new severe acute respiratory syndrome coronavirus-2 infections (0.4%) were detected. Seven of those COVID-19 cases (26% of all new cases) were asymptomatic and had no positive contact history, but were identified through a positive PCR test. The number needed to identify an asymptomatic patient was 425 in the first wave of the epidemic, 1218 in the low incidence phase. The specificity of the method was above 99.9%. Universal PCR testing was highly accepted by staff as demonstrated by high compliance. The costs to detect one asymptomatic case in future studies need to be traded off against the costs and damage caused by potential outbreaks of COVID-19.
© 2021 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; admission screening; infection control; testing strategy

Mesh:

Year:  2021        PMID: 33386772     DOI: 10.1002/jmv.26770

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2.

Authors:  Thierry Burnouf; Birgit Gathof; Evan M Bloch; Renée Bazin; Vincenzo de Angelis; Gopal Kumar Patidar; Rada M Grubovic Rastvorceva; Adaeze Oreh; Ruchika Goel; Naomi Rahimi-Levene; Salwa Hindawi; Arwa Z Al-Riyami; Cynthia So-Osman
Journal:  Transfus Med Rev       Date:  2022-06-09

Review 2.  Rapid Antigen Assays for SARS-CoV-2: Promise and Peril.

Authors:  Thao T Truong; Jennifer Dien Bard; Susan M Butler-Wu
Journal:  Clin Lab Med       Date:  2022-03-04       Impact factor: 2.172

3.  Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum.

Authors:  Manuel Krone; Julia Gütling; Johannes Wagener; Thiên-Trí Lâm; Christoph Schoen; Ulrich Vogel; August Stich; Florian Wedekink; Jörg Wischhusen; Thomas Kerkau; Niklas Beyersdorf; Silvana Klingler; Simone Backes; Lars Dölken; Georg Gasteiger; Oliver Kurzai; Alexandra Schubert-Unkmeir
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

4.  COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting.

Authors:  Jen-Yu Hsu; Po-Yu Liu; Chien-Hao Tseng; Chia-Wei Liu; Wan-Ting Yang; Wei-Hsuan Huang; Shu-Yuan Li; Ya-Chun Liao; Ming-Ju Wu
Journal:  J Multidiscip Healthc       Date:  2021-10-27

5.  Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis.

Authors:  Qiuyue Ma; Jue Liu; Qiao Liu; Liangyu Kang; Runqing Liu; Wenzhan Jing; Yu Wu; Min Liu
Journal:  JAMA Netw Open       Date:  2021-12-01

6.  ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting.

Authors:  Elena Carrara; David S Y Ong; Khetam Hussein; Siran Keske; Anders F Johansson; Elisabeth Presterl; Constantinos Tsioutis; Sarah Tschudin-Sutter; Evelina Tacconelli
Journal:  Clin Microbiol Infect       Date:  2022-02-03       Impact factor: 13.310

7.  Provision of safe patient care during the COVID-19 pandemic despite shared patient rooms in a tertiary hospital.

Authors:  Astrid Füszl; Lukas Bouvier-Azula; Miriam Van den Nest; Julia Ebner; Robert Strassl; Cornelia Gabler; Magda Diab-Elschahawi; Elisabeth Presterl
Journal:  Antimicrob Resist Infect Control       Date:  2022-04-21       Impact factor: 6.454

8.  Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits.

Authors:  Xuetong Zhu; Fengyan Zhou; Qi Zhou; Jiancheng Xu
Journal:  Front Public Health       Date:  2022-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.